In this interview, Dr. Michelle Fraser highlights how base editing and AI-designed enzymes are expanding therapeutic ...
In this interview, James Atwood, CEO of Opentrons, discusses the tasks most ripe for automation today, what “autonomous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results